bevacizumab,atezolizumab
roche
['imbrave050', 'hcc', 'atezo']
 #aacr23 imbrave050 phase 3 trial shows significantly improved rfs with adjuvant atezo+bev vs surveillance in pts with resected/ablated high-risk hcc. first positive adjuvant trial in hepatocellular carcinoma!! could change practice - but os still immature. 
Academic GI Cancer Centre in the City of London. Delivering evidence-based treatments and clinical trials to patients. Informing and education patients and HCPs